Interestingly, the study identified a distinct germline variant at T-cell leukemia/lymphoma protein 1A (TCL1A) that exhibited an opposing impact on DNMT3A and TET2, emphasizing the intricate interplay between germline genetic factors and the manifestation of CH. This evidence concerns the gene TET2 and cyclic hematopoiesis.